Explaining the decrease in U.S. deaths from coronary disease, 1980-2000
Earl S Ford, Umed A Ajani, Janet B Croft, Julia A Critchley, Darwin R Labarthe, Thomas E Kottke, Wayne H Giles, Simon Capewell, Earl S Ford, Umed A Ajani, Janet B Croft, Julia A Critchley, Darwin R Labarthe, Thomas E Kottke, Wayne H Giles, Simon Capewell
Abstract
Background: Mortality from coronary heart disease in the United States has decreased substantially in recent decades. We conducted a study to determine how much of this decrease could be explained by the use of medical and surgical treatments as opposed to changes in cardiovascular risk factors.
Methods: We applied a previously validated statistical model, IMPACT, to data on the use and effectiveness of specific cardiac treatments and on changes in risk factors between 1980 and 2000 among U.S. adults 25 to 84 years old. The difference between the observed and expected number of deaths from coronary heart disease in 2000 was distributed among the treatments and risk factors included in the analyses.
Results: From 1980 through 2000, the age-adjusted death rate for coronary heart disease fell from 542.9 to 266.8 deaths per 100,000 population among men and from 263.3 to 134.4 deaths per 100,000 population among women, resulting in 341,745 fewer deaths from coronary heart disease in 2000. Approximately 47% of this decrease was attributed to treatments, including secondary preventive therapies after myocardial infarction or revascularization (11%), initial treatments for acute myocardial infarction or unstable angina (10%), treatments for heart failure (9%), revascularization for chronic angina (5%), and other therapies (12%). Approximately 44% was attributed to changes in risk factors, including reductions in total cholesterol (24%), systolic blood pressure (20%), smoking prevalence (12%), and physical inactivity (5%), although these reductions were partially offset by increases in the body-mass index and the prevalence of diabetes, which accounted for an increased number of deaths (8% and 10%, respectively).
Conclusions: Approximately half the decline in U.S. deaths from coronary heart disease from 1980 through 2000 may be attributable to reductions in major risk factors and approximately half to evidence-based medical therapies.
Copyright 2007 Massachusetts Medical Society.
Source: PubMed
即将进行的临床试验
-
Enveda Therapeutics尚未招聘
-
Karabuk University尚未招聘肌肉骨骼疼痛 | 体力活动 | 胃食管反流病 (GERD) | 症状
-
Peking University First Hospital尚未招聘术后疼痛 | 老年人 | 髋部骨折手术 | 髂筋膜阻滞 | 脂质体布比卡因中国
-
The First Affiliated Hospital with Nanjing Medical...尚未招聘
-
Government of JerseyUniversity of Oxford尚未招聘
-
Azienda Ospedaliera Bolognini di Seriate Bergamo尚未招聘
-
BillionToOne Inc.招聘中非整倍体 | 22q11.2 缺失综合征 | 18 三体 | 13 三体 | 性染色体异常 | 唐氏综合症(21 三体) | Pregnant Individuals美国
-
Boston Medical CenterWagner Foundation尚未招聘
-
Beijing Tiantan HospitalThe First Affiliated Hospital of Nanchang University; Chinese PLA General Hospital; Second Affiliated... 和其他合作者尚未招聘蛛网膜下腔出血,动脉瘤性 | 蛛网膜下腔出血后脑血管痉挛中国
-
Central Hospital, Nancy, France尚未招聘